Abstract: At present, granulocyte transfusions (GT) are used less and less frequently for infection control in patients with acute myeloid leukemia (AML). Application of GT is limited because of its low efficacy and potential adverse effects. It has been largely replaced by newly developed antibiotics and granulocyte colony stimulating (G-CSF) therapy. However, GT is considered useful in patients with serious infections caused by resistant bacteria or when G-CSF is ineffective. We describe our experience with GT in a patient with AML who underwent tooth extraction.

